It seems like it would be a great drug on the balance of scales if low blood volume POTS was DXed easier and the patient had low VEGF.
I wish like at
@Kati post on Zika virus the NIH would be rigoroulsy testing and repurposing drugs based on what information they have about ME/CFS currently.
The NIH has enough info already it really needs to use this information to come up with some options.
For example if in a study 5 people out of 20 have X, Y, Z markers than find a drug or drugs that can help those 5. Then on to the next batch...etc.
Zika can spread easily which is very concerning but so many millions have ME and/or Lyme that really need effective treatment options.